Avalo, Inc. — Form D
Avalo, Inc. of DURHAM, NC, a company, filed a Form D exempt-offering notice with the SEC on 2022-02-07. The offering totals $1.1M, of which $500K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-02-07
- Form: D
- Accession: 0001875179-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.1M
- Amount sold: $500K
- Remaining: $600K
- Investors: 2
- Date of first sale: 2021-12-31
- Revenue range: Decline to Disclose
- SEC file number: 021-432631
Issuer
- Name: Avalo, Inc.
- CIK: 0001875179
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 1501 HOLLYWOOD STREET, DURHAM, NC, 27701
- Phone: 919-627-8065
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Mariano Alvarez | Director | Durham, NC |
| Brendan Collins | Director | Boulder, CO |
| Laurie Menoud | Director | Waltham, MA |
| Mariano Alvarez | Executive Officer | Durham, NC |
| Brendan Collins | Executive Officer | Boulder, CO |
| Mariano Alvarez | Promoter | Durham, NC |
| Brendan Collins | Promoter | Boulder, CO |
Other filings by this issuer (1)
More